European stocks rose Friday, alongside U.S. equity futures as investors waited to see if the latest American jobs numbers will show damage from the resurgent pandemic. Drug and energy companies were leading the gains.
The Stoxx Europe 600 index
rose 0.2% after a mostly flat session Thursday. The index has gained 0.8% this week to kick off the last trading month of 2021. The FTSE 100 UK:UKX led the regional indexes with a 0.7% gain, while the German DAX
was flat and the French CAC 40
U.S. stock futures rose. On Thursday, the Dow Jones Industrial Average
closed higher and S&P 500
finished lower, but both off intraday highs after Pfizer
said it expected to ship only half of the vaccines it had planned to deliver this year. The Nasdaq Composite
booked a new closing record.
Read: Biden to call for 100 days of mask-wearing, will keep Fauci as chief medical adviser
Investors are waiting for U.S. payrolls data, which is expected to show jobs growth slowed in November amid a surge in COVID-19 cases and deaths in recent weeks. Economists polled by MarketWatch are predicting a 438,000 rise, down from the 638,000 gain seen in the previous month.
In Europe, data from Germany showed manufacturing orders rose for the sixth straight month ahead of a second lockdown.
Major oil companies were higher, with shares of Royal Dutch Shell
continued to rise after the Organization of the Petroleum Exporting Countries and their allies on Thursday agreed to a gradual rise in crude production starting in January, defying earlier expectations for an extension of current cuts in output.
Leading the Stoxx 600 gainers, shares of Dassault Aviation
climbed over 6% after a report in French weekly financial newspaper, La Tribune, that Indonesia may buy 48 Rafale jet fighters.
Shares of Associated British Foods
rose nearly 3% after the U.K. conglomerate said autumn store closures likely cost it 430 million pounds ($578.4 million) in sales, but that it still expects full-year Primark revenue and profit to beat fiscal 2020 results.
Also contributing to the Stoxx 600 gains, shares of heavily weighted drugmakers AstraZeneca